β PCP and its analogues are potent dissociatives with significant risk of psychosis, violent behavior, and overdose. Effects are highly unpredictable and dose-sensitive.
π§ͺThis is a research chemical with limited data on its long-term health effects, toxicity profile, and safe dosage ranges.
3-HO-PCP is a potent dissociative first synthesized in 1978. Uniquely among arylcyclohexylamines, it has appreciable ΞΌ-opioid receptor activity in animal models, though the extent of opioid effects in humans remains unclear. Reports suggest it may produce more physical side effects (muscle soreness, flu-like symptoms) than related dissociatives, especially at higher doses.
Perspectives
“Unlike every other exclusively 3-substituted arylcyclohexamine Iβve tried, this was not functional or stimulating in the least. It was a powerful, all encompassing, annihilating experience that thrashed me about like a raft in a hurricane.”
“This was in fact quite a decent experience, tempting a potential return.”
Build-updevelops with repeated use over days to weeks
Reset2β4 weeks for noticeable reduction
Tolerance Decay
Full tolerance
2dHalf tolerance
3dBaseline
~14d
Tolerance builds rapidly with repeated use over days and decays over 1β2+ weeks; numbers are approximate and largely anecdotal for this specific analogue.